Page last updated: 2024-11-13

bof 4272

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID23698229
MeSH IDM0197447

Synonyms (10)

Synonym
bof-4272
sodium-8-(3-methoxy-4-phenylsulfinylphenyl)pyrazolo (1,5-a)-1,3,5-triazine-4-olate monohydrate
bof 4272
pyrazolo(1,5-a)-1,3,5-triazin-4(1h)-one, 8-(3-methoxy-4-(phenylsulfinyl)phenyl)-, sodium salt, (+-)-
unii-2q33d25zxe
142181-44-0
2q33d25zxe ,
pyrazolo(1,5-a)-1,3,5-triazin-4(3h)-one, 8-(3-methoxy-4-(phenylsulfinyl)phenyl)-, sodium salt (1:1)
Q27255463
sodium;7-[4-(benzenesulfinyl)-3-methoxyphenyl]-1,3,9-triaza-5-azanidabicyclo[4.3.0]nona-3,6,8-trien-2-one

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" to healthy male volunteers to evaluate its pharmacokinetic and pharmacodynamic properties."( Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers.
Nakashima, M; Uematsu, T, 1994
)
0.29
" The elimination half-life of the distribution phase (t1/2(alpha)) was similar in mice (0."( Pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, after single intravenous or oral administration to male mice and rats.
Naito, S; Nishimura, M; Nogawa, H, 1999
)
0.3
" The elimination half-life of BOF-4272 in the liver was 5-1-fold longer than that in the plasma."( Evaluation of the pharmacological actions and pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, in mouse liver.
Naito, S; Nishimura, M; Tamao, Y, 2000
)
0.31
" BOF-4269 was detected in dog plasma after a lag time following the oral administration of BOF-4272, and the Cmax and AUC0-t of BOF-4269 were higher in fed dogs than in fasted dogs after the oral administration of BOF-4272."( Metabolic pathways and pharmacokinetics of BOF-4272, a sulfoxide-containing drug, in the dog: in vivo and in vitro studies.
Naito, S; Nishimura, M; Nogawa, H; Yoshitsugu, H, 1999
)
0.3

Dosage Studied

ExcerptRelevanceReference
" The area under the concentration time curve (aucH) of BOF-4272 was proportional to the dosing amount, and the mean transit time was constant from 62."( Local disposition of a new xanthine oxidase/xanthine dehydrogenase inhibitor, BOF-4272, in rat liver.
Naito, S; Nakagawa, T; Nishimura, M; Yamaoka, K; Yasui, H, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's19 (67.86)18.2507
2000's9 (32.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.77 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.45%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (96.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]